Archive: Vaccine
-
Statement from Jesse L. Goodman, MD, MPH, on FDA Approval of Pfizer-BioNTech’s COVID-19 Vaccine
WASHINGTON (August 23, 2021) — Today, the U.S. Food & Drug Administration approved the two-dose COVID-19 Pfizer-BioNTech vaccine. Jesse L. Goodman, MD, MPH, professor of medicine and infectious diseases at Georgetown University Medical Center and former FDA Chief Scientist, shares the following comments: “In addition to evaluating the vaccine’s safety and efficacy in preventing COVID, FDA has […]
Category: News Release
-
Georgetown’s Jesse Goodman Leads Vaccine Analysis Team
(May 7, 2021) — If you’ve read news stories this past year about COVID-19 vaccines in The Washington Post or The New York Times, for example, or have heard stories on NPR, the journalists’ reporting may well have been informed by input from a group of vaccine experts led by Georgetown infectious disease specialist Jesse […]
Category: GUMC Stories
-
Clinical Students Volunteer With COVID-19 Vaccinations
(February 19, 2021) — Since mid-January, more than 150 medical and nursing students at Georgetown have answered MedStar Health’s call for volunteers to administer the COVID-19 vaccine. Coordinated by Elizabeth Zolper (M’21), the students volunteer every day of the week at four MedStar Health locations around Washington, D.C. Throughout this pandemic, students have contributed to […]
Category: GUMC Stories